June 3, 2020 / Berkeley Lovelace Jr., William Feuer The World Health Organization is resuming its trial of hydroxychloroquine, the malaria drug backed by President Donald Trump to combat the deadly coronavirus, after temporarily halting research over safety concerns.  The Data Safety Monitoring Board decided there was no reason to discontinue the international trial after reviewing available data …